Literature DB >> 14553821

Matrix metalloproteinases: a review of their structure and role in acute coronary syndrome.

Charles B Jones1, David C Sane, David M Herrington.   

Abstract

OBJECTIVE: To summarize the structure, function, and regulation of matrix metalloproteinases (MMPs) and to review the literature to date on their potential role in the pathogenesis of acute coronary syndromes.
METHODS: A recursive strategy starting with a Medline Search for primary articles in the last decade, followed by identification of additional articles of interest among the cited literature in the primary articles, followed by identification of additional articles of interest cited in the secondary articles.
RESULTS: MMPs play a central role in many fundamental processes in human health and disease. In vitro evidence suggests that MMP activity may facilitate atherosclerosis, plaque destabilization, and platelet aggregation. Limited evidence from clinical studies supports a role of MMPs in the development of acute coronary syndromes.
CONCLUSIONS: MMP activity likely contributes to the development of acute coronary syndromes and may be an important therapeutic target for future drug development.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 14553821     DOI: 10.1016/s0008-6363(03)00516-9

Source DB:  PubMed          Journal:  Cardiovasc Res        ISSN: 0008-6363            Impact factor:   10.787


  77 in total

Review 1.  Matrix metalloproteinase inhibitors as investigative tools in the pathogenesis and management of vascular disease.

Authors:  Mina M Benjamin; Raouf A Khalil
Journal:  Exp Suppl       Date:  2012

Review 2.  Matrix Metalloproteinases, Vascular Remodeling, and Vascular Disease.

Authors:  Xi Wang; Raouf A Khalil
Journal:  Adv Pharmacol       Date:  2017-09-19

3.  Matrix metalloproteinases and membrane damage markers in sera of patients with acute myocardial infarction.

Authors:  Kristina Gopcevic; Branislav Rovcanin; Dusan Kekic; Sandra Radenkovic
Journal:  Mol Cell Biochem       Date:  2010-12-28       Impact factor: 3.396

Review 4.  Matrix metalloproteinases and their inhibitors in vascular remodeling and vascular disease.

Authors:  Joseph D Raffetto; Raouf A Khalil
Journal:  Biochem Pharmacol       Date:  2007-07-07       Impact factor: 5.858

5.  Matrix metalloproteinase 3 is present in the cell nucleus and is involved in apoptosis.

Authors:  Karim Si-Tayeb; Arnaud Monvoisin; Claire Mazzocco; Sébastien Lepreux; Marion Decossas; Gaëlle Cubel; Danièle Taras; Jean-Frédéric Blanc; Derrick R Robinson; Jean Rosenbaum
Journal:  Am J Pathol       Date:  2006-10       Impact factor: 4.307

6.  The Role of Matrix Metalloproteinase-3 In the Development of Atherosclerosis and Cardiovascular Events.

Authors:  Krintus Magdalena; Kuligowska Magdalena; Sypniewska Grazyna
Journal:  EJIFCC       Date:  2006-03-20

Review 7.  Molecular imaging in cardiovascular disease: targets and opportunities.

Authors:  Stanley Y Shaw
Journal:  Nat Rev Cardiol       Date:  2009-07-21       Impact factor: 32.419

8.  Hispolon inhibits TPA-induced invasion by reducing MMP-9 expression through the NF-κB signaling pathway in MDA-MB-231 human breast cancer cells.

Authors:  Yi-Sheng Sun; Zhao Zhao; Han-Ping Zhu
Journal:  Oncol Lett       Date:  2015-05-18       Impact factor: 2.967

9.  MMPs 2 and 9 are essential for coronary collateral growth and are prominently regulated by p38 MAPK.

Authors:  Tracy Dodd; Rashmi Jadhav; Luke Wiggins; James Stewart; Erika Smith; James C Russell; Petra Rocic
Journal:  J Mol Cell Cardiol       Date:  2011-08-22       Impact factor: 5.000

10.  Blood flow interplays with elastin: collagen and MMP: TIMP ratios to maintain healthy vascular structure and function.

Authors:  Poulami Basu; Utpal Sen; Neetu Tyagi; Suresh C Tyagi
Journal:  Vasc Health Risk Manag       Date:  2010-04-15
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.